MAPT and Alzheimer disease: Currently, the available therapy of enhancing the acetylcholine response is not very satisfactory, and the trials targeting Aβ in AD repeatedly failed [5]; therefore, the microtubule associated protein tau (MAPT) hypothesis has gained much attention.